Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Protein Disulfide-Isomerases | 23 | 2019 | 207 | 7.110 |
Why?
|
Thrombosis | 49 | 2018 | 3052 | 3.980 |
Why?
|
Thromboplastin | 19 | 2020 | 286 | 3.600 |
Why?
|
Blood Platelets | 31 | 2019 | 2520 | 3.250 |
Why?
|
Fibrin | 17 | 2018 | 505 | 2.120 |
Why?
|
Blood Coagulation | 22 | 2019 | 1157 | 2.080 |
Why?
|
P-Selectin | 15 | 2018 | 599 | 1.390 |
Why?
|
Platelet Activation | 11 | 2018 | 660 | 1.170 |
Why?
|
Integrin beta3 | 4 | 2015 | 121 | 1.070 |
Why?
|
Cell-Derived Microparticles | 5 | 2012 | 161 | 0.930 |
Why?
|
Thrombin | 6 | 2018 | 593 | 0.920 |
Why?
|
beta 2-Glycoprotein I | 2 | 2014 | 28 | 0.850 |
Why?
|
Endothelial Cells | 8 | 2019 | 3539 | 0.800 |
Why?
|
Antiphospholipid Syndrome | 3 | 2017 | 165 | 0.760 |
Why?
|
Lasers | 7 | 2015 | 952 | 0.730 |
Why?
|
Blood Coagulation Disorders, Inherited | 1 | 2020 | 19 | 0.730 |
Why?
|
1-Carboxyglutamic Acid | 8 | 2006 | 20 | 0.690 |
Why?
|
Arterioles | 5 | 2012 | 250 | 0.680 |
Why?
|
Complement Pathway, Mannose-Binding Lectin | 1 | 2019 | 28 | 0.660 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 5 | 2017 | 638 | 0.650 |
Why?
|
Frameshift Mutation | 1 | 2020 | 388 | 0.630 |
Why?
|
Vitamin K | 3 | 2014 | 321 | 0.620 |
Why?
|
Rutin | 2 | 2015 | 16 | 0.620 |
Why?
|
Microscopy, Video | 7 | 2012 | 242 | 0.610 |
Why?
|
Disulfides | 4 | 2019 | 466 | 0.600 |
Why?
|
Factor VIIIa | 3 | 2008 | 16 | 0.600 |
Why?
|
Membrane Glycoproteins | 11 | 2010 | 3707 | 0.590 |
Why?
|
Lectins | 1 | 2019 | 484 | 0.560 |
Why?
|
Factor IXa | 2 | 2008 | 19 | 0.540 |
Why?
|
Disease Models, Animal | 14 | 2020 | 18137 | 0.530 |
Why?
|
Endothelium | 3 | 2017 | 764 | 0.520 |
Why?
|
Platelet Aggregation | 7 | 2018 | 805 | 0.510 |
Why?
|
Blood Vessels | 2 | 2016 | 1112 | 0.510 |
Why?
|
Hermanski-Pudlak Syndrome | 1 | 2015 | 20 | 0.490 |
Why?
|
Rodenticides | 1 | 2014 | 21 | 0.490 |
Why?
|
Phenprocoumon | 1 | 2013 | 20 | 0.460 |
Why?
|
Acenocoumarol | 1 | 2013 | 19 | 0.460 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2014 | 71 | 0.460 |
Why?
|
Anticoagulants | 3 | 2014 | 4897 | 0.450 |
Why?
|
Protein Multimerization | 1 | 2019 | 983 | 0.450 |
Why?
|
Factor VIII | 4 | 2010 | 349 | 0.440 |
Why?
|
Blood Coagulation Disorders | 2 | 2014 | 349 | 0.440 |
Why?
|
Fibrinolytic Agents | 6 | 2017 | 2167 | 0.440 |
Why?
|
Vascular System Injuries | 1 | 2017 | 247 | 0.440 |
Why?
|
Catalytic Domain | 7 | 2019 | 706 | 0.430 |
Why?
|
Animals | 68 | 2020 | 167963 | 0.420 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2013 | 253 | 0.410 |
Why?
|
Conotoxins | 4 | 2006 | 20 | 0.400 |
Why?
|
Quercetin | 3 | 2019 | 97 | 0.400 |
Why?
|
Kinetics | 11 | 2019 | 6377 | 0.400 |
Why?
|
Blood Coagulation Factors | 4 | 2017 | 365 | 0.400 |
Why?
|
Platelet Adhesiveness | 3 | 2007 | 154 | 0.390 |
Why?
|
Mice, Inbred C57BL | 24 | 2020 | 22023 | 0.390 |
Why?
|
Urokinase-Type Plasminogen Activator | 5 | 2017 | 326 | 0.370 |
Why?
|
Glycoproteins | 1 | 2019 | 2208 | 0.370 |
Why?
|
Carbon-Carbon Ligases | 3 | 2007 | 19 | 0.360 |
Why?
|
Enoxaparin | 1 | 2012 | 397 | 0.350 |
Why?
|
Flow Cytometry | 2 | 2012 | 5870 | 0.350 |
Why?
|
Plasminogen Activator Inhibitor 1 | 3 | 2017 | 278 | 0.340 |
Why?
|
Mice | 41 | 2020 | 81208 | 0.330 |
Why?
|
Hemorrhage | 3 | 2016 | 3600 | 0.290 |
Why?
|
Substrate Specificity | 4 | 2019 | 1792 | 0.280 |
Why?
|
Mice, Knockout | 15 | 2020 | 14372 | 0.280 |
Why?
|
Mollusca | 2 | 2005 | 40 | 0.280 |
Why?
|
von Willebrand Factor | 2 | 2010 | 673 | 0.280 |
Why?
|
Thromboembolism | 2 | 2012 | 1017 | 0.280 |
Why?
|
Oxidation-Reduction | 3 | 2019 | 2222 | 0.270 |
Why?
|
Autoantibodies | 2 | 2014 | 2118 | 0.260 |
Why?
|
Leukocytes | 5 | 2007 | 2026 | 0.260 |
Why?
|
Calcium | 9 | 2010 | 5725 | 0.240 |
Why?
|
Warfarin | 1 | 2013 | 1518 | 0.240 |
Why?
|
Protein Binding | 12 | 2017 | 9335 | 0.230 |
Why?
|
Integrin alphaVbeta3 | 2 | 2017 | 105 | 0.230 |
Why?
|
Models, Molecular | 9 | 2017 | 5434 | 0.230 |
Why?
|
Cell Membrane | 7 | 2018 | 3682 | 0.230 |
Why?
|
Factor IX | 1 | 2004 | 77 | 0.230 |
Why?
|
Vitronectin | 2 | 2017 | 40 | 0.220 |
Why?
|
Protein Structure, Tertiary | 12 | 2016 | 3800 | 0.220 |
Why?
|
Microcirculation | 6 | 2006 | 1278 | 0.220 |
Why?
|
Particle Size | 4 | 2011 | 1644 | 0.210 |
Why?
|
Selectins | 1 | 2002 | 101 | 0.210 |
Why?
|
Neoplasms | 6 | 2019 | 22072 | 0.200 |
Why?
|
Dermatitis, Contact | 1 | 2002 | 133 | 0.200 |
Why?
|
Venous Thromboembolism | 2 | 2019 | 1864 | 0.200 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2004 | 465 | 0.200 |
Why?
|
Protein Processing, Post-Translational | 5 | 2005 | 1974 | 0.200 |
Why?
|
Humans | 62 | 2020 | 760621 | 0.190 |
Why?
|
Phenylalanine | 1 | 2003 | 365 | 0.190 |
Why?
|
Models, Biological | 6 | 2016 | 9467 | 0.190 |
Why?
|
Collagen | 2 | 2009 | 2636 | 0.190 |
Why?
|
Leukocyte Rolling | 3 | 2007 | 69 | 0.190 |
Why?
|
Peptide Chain Termination, Translational | 1 | 2020 | 29 | 0.190 |
Why?
|
Vasculitis | 1 | 2005 | 523 | 0.180 |
Why?
|
Mollusk Venoms | 3 | 2004 | 19 | 0.180 |
Why?
|
Enzyme Inhibitors | 4 | 2016 | 3726 | 0.180 |
Why?
|
Cysteine Endopeptidases | 1 | 2003 | 548 | 0.180 |
Why?
|
Peptide Fragments | 5 | 2017 | 5125 | 0.180 |
Why?
|
Genotype | 2 | 2019 | 12960 | 0.180 |
Why?
|
Blotting, Western | 3 | 2015 | 5039 | 0.170 |
Why?
|
Codon, Nonsense | 1 | 2020 | 281 | 0.160 |
Why?
|
Haploinsufficiency | 1 | 2020 | 329 | 0.160 |
Why?
|
Endothelium, Vascular | 7 | 2015 | 4433 | 0.160 |
Why?
|
Amino Acid Sequence | 11 | 2016 | 13451 | 0.160 |
Why?
|
Recombinant Proteins | 7 | 2018 | 6538 | 0.150 |
Why?
|
Inhibitory Concentration 50 | 2 | 2016 | 465 | 0.150 |
Why?
|
Myosin Heavy Chains | 1 | 2019 | 402 | 0.150 |
Why?
|
Receptors, Proteinase-Activated | 2 | 2008 | 19 | 0.150 |
Why?
|
Microscopy, Fluorescence | 4 | 2009 | 2651 | 0.150 |
Why?
|
Microscopy, Confocal | 3 | 2012 | 1972 | 0.150 |
Why?
|
Bone Marrow Cells | 2 | 2004 | 2414 | 0.150 |
Why?
|
Microscopy | 1 | 2002 | 885 | 0.140 |
Why?
|
Cells, Cultured | 6 | 2017 | 18957 | 0.140 |
Why?
|
Bone Marrow Transplantation | 3 | 2012 | 2693 | 0.140 |
Why?
|
Crystallography, X-Ray | 7 | 2016 | 1982 | 0.140 |
Why?
|
Catalysis | 1 | 2019 | 775 | 0.140 |
Why?
|
Cell Movement | 4 | 2009 | 5206 | 0.140 |
Why?
|
Drug Design | 4 | 2017 | 1061 | 0.140 |
Why?
|
Surface Plasmon Resonance | 2 | 2015 | 265 | 0.130 |
Why?
|
Base Sequence | 5 | 2020 | 12446 | 0.130 |
Why?
|
L-Selectin | 3 | 2007 | 209 | 0.130 |
Why?
|
Transplantation Chimera | 2 | 2012 | 595 | 0.130 |
Why?
|
Molecular Sequence Data | 10 | 2007 | 17624 | 0.130 |
Why?
|
Blood Platelet Disorders | 1 | 2016 | 61 | 0.130 |
Why?
|
Calorimetry | 1 | 2015 | 129 | 0.130 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3616 | 0.130 |
Why?
|
Scattering, Small Angle | 1 | 2015 | 64 | 0.130 |
Why?
|
X-Ray Diffraction | 1 | 2015 | 421 | 0.120 |
Why?
|
Binding Sites | 3 | 2015 | 6048 | 0.120 |
Why?
|
DNA, Complementary | 4 | 2006 | 1991 | 0.110 |
Why?
|
Cell Degranulation | 1 | 2015 | 276 | 0.110 |
Why?
|
Adenosine Diphosphate | 1 | 2015 | 429 | 0.110 |
Why?
|
Heterozygote | 1 | 2020 | 2798 | 0.110 |
Why?
|
Hemostasis | 1 | 2016 | 468 | 0.110 |
Why?
|
Exocytosis | 1 | 2015 | 319 | 0.110 |
Why?
|
E-Selectin | 3 | 2009 | 576 | 0.110 |
Why?
|
Lymphocyte Activation | 2 | 2010 | 5496 | 0.110 |
Why?
|
Algorithms | 1 | 2013 | 13981 | 0.110 |
Why?
|
Mice, Mutant Strains | 3 | 2012 | 1753 | 0.110 |
Why?
|
Prothrombin | 2 | 2011 | 191 | 0.100 |
Why?
|
Genetic Association Studies | 2 | 2019 | 2717 | 0.100 |
Why?
|
Protein Folding | 1 | 2016 | 867 | 0.100 |
Why?
|
Apyrase | 1 | 2015 | 373 | 0.100 |
Why?
|
Cell Adhesion | 5 | 2009 | 3094 | 0.100 |
Why?
|
Vesicular Transport Proteins | 1 | 2015 | 374 | 0.100 |
Why?
|
Peptides, Cyclic | 2 | 2004 | 392 | 0.100 |
Why?
|
Ferric Compounds | 3 | 2009 | 377 | 0.100 |
Why?
|
CHO Cells | 2 | 2012 | 1389 | 0.100 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2012 | 95 | 0.100 |
Why?
|
Mice, 129 Strain | 1 | 2012 | 372 | 0.100 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2012 | 322 | 0.090 |
Why?
|
Neoplasm Proteins | 1 | 2003 | 3610 | 0.090 |
Why?
|
Chlorides | 3 | 2009 | 663 | 0.090 |
Why?
|
Flavonoids | 1 | 2014 | 445 | 0.090 |
Why?
|
Fibrinogen | 1 | 2014 | 886 | 0.090 |
Why?
|
Factor Xa | 2 | 2018 | 168 | 0.090 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2012 | 418 | 0.090 |
Why?
|
Cricetinae | 2 | 2012 | 2427 | 0.090 |
Why?
|
Endoplasmic Reticulum | 1 | 2016 | 1132 | 0.090 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2014 | 1126 | 0.090 |
Why?
|
Extracellular Space | 1 | 2012 | 564 | 0.090 |
Why?
|
Hemolysis | 1 | 2012 | 423 | 0.090 |
Why?
|
Nitric Oxide | 1 | 2018 | 2141 | 0.080 |
Why?
|
Male | 18 | 2020 | 359744 | 0.080 |
Why?
|
Fucosyltransferases | 1 | 2009 | 117 | 0.080 |
Why?
|
Simvastatin | 1 | 2012 | 352 | 0.080 |
Why?
|
Ligands | 6 | 2010 | 3276 | 0.080 |
Why?
|
Crystallography | 2 | 2011 | 116 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2002 | 4550 | 0.080 |
Why?
|
Skin | 1 | 2002 | 4466 | 0.080 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 1846 | 0.080 |
Why?
|
Mesentery | 1 | 2009 | 202 | 0.080 |
Why?
|
Sterol Esterase | 1 | 2007 | 40 | 0.080 |
Why?
|
Calcium Signaling | 3 | 2007 | 732 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2019 | 10827 | 0.080 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2007 | 2753 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3804 | 0.070 |
Why?
|
Antibodies | 3 | 2006 | 2421 | 0.070 |
Why?
|
Receptors, Cell Surface | 2 | 2008 | 2825 | 0.070 |
Why?
|
Structural Homology, Protein | 1 | 2007 | 86 | 0.070 |
Why?
|
Fura-2 | 1 | 2007 | 107 | 0.070 |
Why?
|
Endothelium, Lymphatic | 1 | 2007 | 63 | 0.070 |
Why?
|
Sequence Alignment | 3 | 2007 | 2176 | 0.070 |
Why?
|
Fluorescent Dyes | 2 | 2007 | 1913 | 0.070 |
Why?
|
Female | 14 | 2020 | 391270 | 0.070 |
Why?
|
Phenotype | 3 | 2020 | 16546 | 0.070 |
Why?
|
Factor V | 1 | 2007 | 168 | 0.070 |
Why?
|
Milk Proteins | 1 | 2007 | 163 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 17790 | 0.070 |
Why?
|
Arteries | 1 | 2011 | 1126 | 0.060 |
Why?
|
Cysteine | 3 | 2006 | 895 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3442 | 0.060 |
Why?
|
Muscle, Skeletal | 2 | 2012 | 4925 | 0.060 |
Why?
|
Snails | 4 | 2006 | 21 | 0.060 |
Why?
|
Fibrinolysis | 2 | 2017 | 332 | 0.060 |
Why?
|
Membrane Proteins | 3 | 2015 | 7850 | 0.060 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 2006 | 285 | 0.060 |
Why?
|
Blood Circulation | 1 | 2005 | 249 | 0.060 |
Why?
|
Hypercholesterolemia | 1 | 2012 | 1155 | 0.060 |
Why?
|
Receptors, IgG | 2 | 2006 | 559 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2873 | 0.060 |
Why?
|
Anticholesteremic Agents | 1 | 2012 | 987 | 0.060 |
Why?
|
Chimera | 1 | 2005 | 453 | 0.060 |
Why?
|
Cloning, Molecular | 3 | 2006 | 4169 | 0.060 |
Why?
|
Genetic Variation | 1 | 2019 | 6551 | 0.060 |
Why?
|
Cell Separation | 1 | 2009 | 1720 | 0.060 |
Why?
|
Amino Acid Substitution | 2 | 2011 | 1737 | 0.060 |
Why?
|
Mycobacterium tuberculosis | 1 | 2015 | 1903 | 0.060 |
Why?
|
Blood Cells | 1 | 2005 | 305 | 0.060 |
Why?
|
Cross-Linking Reagents | 2 | 2004 | 685 | 0.060 |
Why?
|
Vitamin K 2 | 1 | 2003 | 47 | 0.060 |
Why?
|
Bleeding Time | 2 | 2017 | 84 | 0.060 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 508 | 0.050 |
Why?
|
Macromolecular Substances | 1 | 2006 | 1433 | 0.050 |
Why?
|
Vitamin K 1 | 1 | 2003 | 47 | 0.050 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2005 | 459 | 0.050 |
Why?
|
Integrin alpha4 | 1 | 2003 | 87 | 0.050 |
Why?
|
Receptors, CXCR4 | 1 | 2007 | 728 | 0.050 |
Why?
|
Macrophages, Peritoneal | 1 | 2003 | 237 | 0.050 |
Why?
|
Microsomes | 1 | 2002 | 252 | 0.050 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2005 | 663 | 0.050 |
Why?
|
Escherichia coli | 1 | 2015 | 4219 | 0.050 |
Why?
|
Lymphatic Vessels | 1 | 2007 | 358 | 0.050 |
Why?
|
Monocytes | 1 | 2012 | 2575 | 0.050 |
Why?
|
Peptides | 5 | 2006 | 4354 | 0.050 |
Why?
|
Cell Culture Techniques | 1 | 2009 | 1664 | 0.050 |
Why?
|
Pyridazines | 1 | 2003 | 200 | 0.050 |
Why?
|
Cell Line | 5 | 2010 | 15620 | 0.050 |
Why?
|
Antibody Specificity | 1 | 2004 | 1060 | 0.050 |
Why?
|
Valine | 1 | 2003 | 409 | 0.050 |
Why?
|
Bacterial Proteins | 1 | 2015 | 3826 | 0.050 |
Why?
|
Middle Aged | 7 | 2019 | 220352 | 0.050 |
Why?
|
Protein Conformation | 4 | 2015 | 3969 | 0.050 |
Why?
|
COS Cells | 1 | 2002 | 1129 | 0.050 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 2 | 2016 | 400 | 0.050 |
Why?
|
Time Factors | 5 | 2005 | 40165 | 0.040 |
Why?
|
Calcium Channels | 1 | 2004 | 619 | 0.040 |
Why?
|
Mutation | 4 | 2019 | 29932 | 0.040 |
Why?
|
Survival Analysis | 1 | 2012 | 10182 | 0.040 |
Why?
|
Aged | 6 | 2019 | 169152 | 0.040 |
Why?
|
Hemostatics | 1 | 2002 | 243 | 0.040 |
Why?
|
Protein Structure, Secondary | 3 | 2007 | 1229 | 0.040 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2005 | 828 | 0.040 |
Why?
|
Cyclic AMP | 1 | 2003 | 1456 | 0.040 |
Why?
|
Metals | 1 | 2004 | 736 | 0.040 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2012 | 3201 | 0.040 |
Why?
|
Open Reading Frames | 1 | 2002 | 814 | 0.040 |
Why?
|
Oligodendroglia | 1 | 2003 | 536 | 0.040 |
Why?
|
Enzyme Activation | 3 | 2011 | 3602 | 0.040 |
Why?
|
Inflammation | 2 | 2012 | 10756 | 0.040 |
Why?
|
Ions | 3 | 2004 | 261 | 0.040 |
Why?
|
Abdominal Muscles | 1 | 2018 | 170 | 0.040 |
Why?
|
Graft vs Host Disease | 1 | 2010 | 3025 | 0.040 |
Why?
|
Plasmids | 1 | 2002 | 2275 | 0.040 |
Why?
|
Serpin E2 | 1 | 2017 | 48 | 0.040 |
Why?
|
Receptors, Urokinase Plasminogen Activator | 2 | 2008 | 75 | 0.040 |
Why?
|
Cell Communication | 1 | 2004 | 1653 | 0.040 |
Why?
|
Sulfhydryl Compounds | 1 | 2018 | 299 | 0.040 |
Why?
|
Biomedical Research | 1 | 2012 | 3426 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2016 | 22053 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2005 | 2050 | 0.030 |
Why?
|
Half-Life | 1 | 2017 | 652 | 0.030 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2017 | 179 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2002 | 1765 | 0.030 |
Why?
|
Agar | 1 | 2015 | 55 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2007 | 3486 | 0.030 |
Why?
|
Down-Regulation | 1 | 2002 | 2913 | 0.030 |
Why?
|
Tryptophan | 2 | 2010 | 479 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2019 | 2471 | 0.030 |
Why?
|
Allosteric Regulation | 1 | 2016 | 426 | 0.030 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2015 | 132 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2016 | 492 | 0.030 |
Why?
|
Electron Transport | 1 | 2015 | 206 | 0.030 |
Why?
|
Mycobacterium smegmatis | 1 | 2015 | 124 | 0.030 |
Why?
|
Mass Spectrometry | 2 | 2015 | 2192 | 0.030 |
Why?
|
Rats | 2 | 2008 | 23711 | 0.030 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2015 | 276 | 0.030 |
Why?
|
Antigens, CD | 1 | 2004 | 4000 | 0.030 |
Why?
|
Prognosis | 1 | 2014 | 29658 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2017 | 1693 | 0.030 |
Why?
|
Protein Engineering | 1 | 2017 | 541 | 0.030 |
Why?
|
Molecular Weight | 2 | 2006 | 2186 | 0.030 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 2 | 2004 | 267 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2002 | 3380 | 0.030 |
Why?
|
Toll-Like Receptor 6 | 1 | 2012 | 29 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2003 | 3106 | 0.020 |
Why?
|
Structure-Activity Relationship | 2 | 2011 | 3084 | 0.020 |
Why?
|
Bone Marrow | 3 | 2009 | 2912 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2019 | 4625 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 1347 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2019 | 1885 | 0.020 |
Why?
|
Pichia | 1 | 2011 | 49 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2003 | 3387 | 0.020 |
Why?
|
Models, Animal | 1 | 2017 | 2117 | 0.020 |
Why?
|
Cattle | 2 | 2007 | 3847 | 0.020 |
Why?
|
Receptors, LDL | 1 | 2012 | 488 | 0.020 |
Why?
|
Histidine | 1 | 2010 | 311 | 0.020 |
Why?
|
Bone Marrow Neoplasms | 1 | 2009 | 101 | 0.020 |
Why?
|
Administration, Oral | 1 | 2017 | 4035 | 0.020 |
Why?
|
Sialoglycoproteins | 1 | 2009 | 315 | 0.020 |
Why?
|
Lipoproteins, LDL | 1 | 2012 | 641 | 0.020 |
Why?
|
Disease Progression | 1 | 2005 | 13502 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2015 | 1949 | 0.020 |
Why?
|
Carcinoembryonic Antigen | 1 | 2009 | 336 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2017 | 3735 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2012 | 680 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6898 | 0.020 |
Why?
|
Toll-Like Receptor 4 | 1 | 2012 | 580 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5201 | 0.020 |
Why?
|
Cholesterol Esters | 1 | 2007 | 73 | 0.020 |
Why?
|
Absorption | 1 | 2007 | 243 | 0.020 |
Why?
|
Escherichia coli Proteins | 1 | 2015 | 1066 | 0.020 |
Why?
|
Oligosaccharides | 1 | 2009 | 405 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2012 | 58995 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 2013 | 0.020 |
Why?
|
Platelet Membrane Glycoprotein IIb | 1 | 2006 | 52 | 0.020 |
Why?
|
Cytosol | 1 | 2010 | 887 | 0.020 |
Why?
|
Pseudomonas aeruginosa | 1 | 2015 | 1276 | 0.020 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 2007 | 141 | 0.020 |
Why?
|
Conus Snail | 1 | 2006 | 7 | 0.020 |
Why?
|
Gene Expression | 1 | 2019 | 7588 | 0.020 |
Why?
|
Epoprostenol | 1 | 2007 | 248 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2009 | 11345 | 0.020 |
Why?
|
Phospholipids | 1 | 2010 | 789 | 0.020 |
Why?
|
Hydrogen Bonding | 1 | 2006 | 291 | 0.020 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2005 | 95 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2016 | 4713 | 0.020 |
Why?
|
Hirudins | 1 | 2006 | 194 | 0.020 |
Why?
|
Peptide Biosynthesis | 1 | 2004 | 52 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2007 | 929 | 0.010 |
Why?
|
Duodenum | 1 | 2007 | 486 | 0.010 |
Why?
|
Phosphotransferases | 1 | 2005 | 303 | 0.010 |
Why?
|
Sodium-Calcium Exchanger | 1 | 2004 | 89 | 0.010 |
Why?
|
Surface Properties | 1 | 2007 | 1161 | 0.010 |
Why?
|
Adult | 3 | 2019 | 219994 | 0.010 |
Why?
|
3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2003 | 48 | 0.010 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2003 | 20 | 0.010 |
Why?
|
Circular Dichroism | 1 | 2004 | 348 | 0.010 |
Why?
|
Neurons | 1 | 2003 | 9426 | 0.010 |
Why?
|
gamma-Glutamylcyclotransferase | 1 | 2003 | 8 | 0.010 |
Why?
|
Cations | 1 | 2004 | 239 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2004 | 3765 | 0.010 |
Why?
|
HIV Envelope Protein gp120 | 1 | 2007 | 915 | 0.010 |
Why?
|
Cystine | 1 | 2003 | 94 | 0.010 |
Why?
|
Hydrolysis | 1 | 2004 | 665 | 0.010 |
Why?
|
src-Family Kinases | 1 | 2005 | 535 | 0.010 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2003 | 214 | 0.010 |
Why?
|
Risk Factors | 1 | 2009 | 74359 | 0.010 |
Why?
|
Whole-Body Irradiation | 1 | 2003 | 433 | 0.010 |
Why?
|
Signal Transduction | 1 | 2005 | 23376 | 0.010 |
Why?
|
DNA Primers | 1 | 2006 | 2819 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 2010 | 1810 | 0.010 |
Why?
|
Protein Precursors | 1 | 2006 | 1134 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2004 | 687 | 0.010 |
Why?
|
Isoenzymes | 1 | 2006 | 1690 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2006 | 1975 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2011 | 2566 | 0.010 |
Why?
|
Insulin | 1 | 2016 | 6597 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2010 | 4810 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2010 | 1881 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2010 | 6216 | 0.010 |
Why?
|
Electrophysiology | 1 | 2004 | 1265 | 0.010 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2003 | 691 | 0.010 |
Why?
|
Lysophospholipids | 1 | 2003 | 339 | 0.010 |
Why?
|
Carotid Arteries | 1 | 2005 | 951 | 0.010 |
Why?
|
Abdomen | 1 | 2007 | 1130 | 0.010 |
Why?
|
Glutathione | 1 | 2003 | 582 | 0.010 |
Why?
|
Macrophage Activation | 1 | 2003 | 554 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21392 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2004 | 1544 | 0.010 |
Why?
|
Arginine | 1 | 2003 | 934 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2004 | 2502 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 65017 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2005 | 1120 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2009 | 4902 | 0.010 |
Why?
|
Protons | 1 | 2004 | 1114 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2004 | 1167 | 0.010 |
Why?
|
Cell Death | 1 | 2003 | 1672 | 0.010 |
Why?
|
Tetrazoles | 1 | 2003 | 905 | 0.010 |
Why?
|
Risk | 1 | 2010 | 9631 | 0.010 |
Why?
|
Infant | 1 | 2019 | 36060 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39261 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2006 | 6068 | 0.010 |
Why?
|
Spinal Cord | 1 | 2005 | 1817 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2005 | 3157 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 42063 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 15789 | 0.010 |
Why?
|
Neuroprotective Agents | 1 | 2003 | 961 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2015 | 7408 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2005 | 2418 | 0.010 |
Why?
|
Cell Division | 1 | 2003 | 4463 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2003 | 2138 | 0.010 |
Why?
|
Antioxidants | 1 | 2003 | 1667 | 0.010 |
Why?
|
Liver | 1 | 2009 | 7509 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2009 | 4319 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2005 | 4490 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 58741 | 0.010 |
Why?
|
Survival Rate | 1 | 2007 | 12808 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2004 | 4541 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2003 | 8158 | 0.010 |
Why?
|
Child | 1 | 2019 | 79806 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 87810 | 0.010 |
Why?
|
Stem Cells | 1 | 2003 | 3523 | 0.010 |
Why?
|
HIV-1 | 1 | 2007 | 6849 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2005 | 10446 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2005 | 16939 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 2005 | 10181 | 0.000 |
Why?
|
United States | 1 | 2012 | 72461 | 0.000 |
Why?
|
Brain | 1 | 2005 | 26951 | 0.000 |
Why?
|